Helen M. Heneghan

Ileal pouch anal anastomosis: analysis of outcome and quality of life in 3707 patients.

Background:Ileal pouch anal anastomosis (IPAA) is the treatment of choice for chronic, medically refractory mucosal ulcerative colitis, indeterminate colitis, familial adenomatous polyposis (FAP), and a select group of patients with Crohns disease. Aim:We report outcomes, complications, and quality of life (QOL) in a cohort of 3707 patients treated at our institution from January 1984 to March 2010. Methods:Data were collected from a prospectively maintained database and chart review of 3707 consecutive primary IPAA cases. Patient demographics, postoperative complications, functional outcomes, and QOL data were available. Follow-up consisted of clinical examination with assessment of pouch function and QOL. Results:A total of 3707 patients underwent primary pouch and 328 underwent redo pouch surgery. Postoperative histopathological diagnoses were mucosal ulcerative colitis (n = 2953, 79.7%), indeterminate colitis (n = 63, 1.7%), FAP (n = 223, 6%), Crohns disease (n = 150, 4%), cancer/dysplasia (n = 97, 2.6%), and others (n = 221, 6.0%). Early perioperative complications were encountered in 33.5% of patients with a mortality rate of 0.1%. Excluding pouchitis, late complications were experienced by 29.1% of patients. Of those patients who had IPAA at our institution, pouch failure occurred in 197 patients (5.3%). During a median follow-up of 84 months, 119 patients (3.2%) required excision of the pouch, 32 (0.8%) had a nonfunctioning pouch, and 46 patients (1.2%) had redo IPAA. Functional outcomes and QOL were good or excellent in 95% of patients and similar in each histopathological subgroup. Conclusions:IPAA is an excellent option for patients with MUC, IC, FAP, and select patients with Crohns disease.

Bariatric surgery and cardiovascular outcomes: a systematic review

Purpose To quantify the impact of bariatric surgery on cardiovascular (CV) risk factors, and on cardiac structure and function. Data sources Three major databases (PubMed, Medline and Cochrane) were searched for original studies written in English. Study selection Original articles reporting CV risk factors or non-invasive imaging parameters for patients undergoing bariatric surgery, from January 1950 to June 2012. Data extraction Data extraction from selected studies was based on protocol-defined criteria that included study design, methods, patient characteristics, surgical procedures, weight loss, changes in CV risk factors, cardiac structure and cardiac function postoperatively. Data synthesis 73 CV risk factor studies involving 19 543 subjects were included (mean age 42 years, 76% female). Baseline prevalence of hypertension, diabetes and hyperlipidaemia were 44%, 24%, and 44%, respectively. Mean follow-up was 57.8 months (range 3–176) and average excess weight loss was 54% (range 16–87%). Postoperative resolution/improvement of hypertension occurred in 63% of subjects, of diabetes in 73% and of hyperlipidaemia in 65%. Echocardiographic data from 713 subjects demonstrated statistically significant improvements in left ventricular mass, E/A ratio, and isovolumic relaxation time postoperatively. Limitations Diagnostic criteria, CV risk factor reporting, and imaging parameters were not uniform across all studies. Study groups were heterogeneous in their demographics, operative technique and follow-up period. Conclusions This systematic review highlights the benefits of bariatric surgery in reducing risk factors for CV disease. There is also evidence for left ventricular hypertrophy regression and improved diastolic function. These observations provide further evidence that bariatric surgery enhances future CV health for obese individuals.

Effect of bariatric surgery on cardiovascular risk profile.

Obesity is associated with increased risk for cardiovascular (CV) disease (CVD) and CV mortality. Bariatric surgery has been shown to resolve or improve CVD risk factors, to varying degrees. The objective of this systematic review was to determine the impact of bariatric surgery on CV risk factors and mortality. A systematic review of the published research was performed to evaluate evidence regarding CV outcomes in morbidly obese bariatric patients. Two major databases (PubMed and the Cochrane Library) were searched. The review included all original reports reporting outcomes after bariatric surgery, published in English, from January 1950 to July 2010. In total, 637 studies were identified from the initial screen. After applying inclusion and exclusion criteria, 52 studies involving 16,867 patients were included (mean age 42 years, 78% women). The baseline prevalence of hypertension, diabetes, and dyslipidemia was 49%, 28%, and 46%, respectively. Mean follow-up was 34 months (range 3 to 155), and the average excess weight loss was 52% (range 16% to 87%). Most studies reported significant decreases postoperatively in the prevalence of CV risk factors, including hypertension, diabetes, and dyslipidemia. Mean systolic pressure reduced from to 139 to 124 mm Hg and diastolic pressure from 87 to 77 mm Hg. C-reactive protein decreased, endothelial function improved, and a 40% relative risk reduction for 10-year coronary heart disease risk was observed, as determined by the Framingham risk score. In conclusion, this review highlights the benefits of bariatric surgery in reducing or eliminating risk factors for CVD. It provides further evidence to support surgical treatment of obesity to achieve CVD risk reduction.

Gastric Bypass Surgery Reduces Plasma Ceramide Subspecies and Improves Insulin Sensitivity in Severely Obese Patients

Bariatric surgery is associated with near immediate remission of type 2 diabetes and hyperlipidemia. The mechanisms underlying restoration of normal glucose tolerance postoperatively are poorly understood. Herein, we examined the effect of Roux‐en‐Y gastric bypass surgery (RYGB) on weight loss, insulin sensitivity, plasma ceramides, proinflammatory markers, and cardiovascular risk factors before and at 3 and 6 months after surgery. Thirteen patients (10 female; age 48.5 ± 2.7 years; BMI, 47.4 ± 1.5 kg/m2) were included in the study, all of whom had undergone laparoscopic RYGB surgery. Insulin sensitivity, inflammatory mediators and fasting lipid profiles were measured at baseline, 3 and 6 months postoperatively, using enzymatic analysis. Plasma ceramide subspecies (C14:0, C16:0, C18:0, C18:1, C20:0, C24:0, and C24:1) were quantified using electrospray ionization tandem mass spectrometry after separation with HPLC. At 3 months postsurgery, body weight was reduced by 25%, fasting total cholesterol, triglycerides, low‐density lipoproteins, and free fatty acids were decreased, and insulin sensitivity was increased compared to presurgery values. These changes were all sustained at 6 months. In addition, total plasma ceramide levels decreased significantly postoperatively (9.3 ± 0.5 nmol/ml at baseline vs. 7.6 ± 0.4 at 3 months, and 7.3 ± 0.3 at 6 months, P < 0.05). At 6 months, the improvement in insulin sensitivity correlated with the change in total ceramide levels (r = −0.68, P = 0.02), and with plasma tumor necrosis factor‐α (TNF‐α) (r = −0.62, P = 0.04). We conclude that there is a potential role for ceramide lipids as mediators of the proinflammatory state and improved insulin sensitivity after gastric bypass surgery.

Bariatric surgery for treatment of obesity

This article focuses on recent trends and outcomes of bariatric surgery. The outcomes discussed include perioperative morbidity and mortality, weight loss, long-term complications and the impact of bariatric surgery on comorbidities, cardiovascular risk and mortality.

Weighing the evidence for an association between obesity and suicide risk

Chronic illness is an important risk factor for suicidal behavior. Obesity is perhaps the most prevalent chronic disease at present, although the contribution of obesity to fatal and nonfatal suicide is controversial. Several large population-based studies have shown that obesity is independently linked to an increased risk of suicide. However, this association has been challenged by reports demonstrating a paradoxical relationship between an increasing body mass index and suicide. Recently, it has also been suggested that bariatric surgery patients are at increased risk of death by suicide postoperatively. We reviewed the heterogeneous data concerning the relationship between obesity and suicide. We also critically examined recent reports describing the incidence of fatal suicide events after bariatric surgery. From the present review, it appears that a positive association between obesity and suicide has been observed more frequently than a negative or absent association. This implies that obese individuals are indeed at an increased risk of suicide. This risk seems to persist despite treatment of obesity with bariatric surgery.

Surgical Management of Obesity and the Relationship to Cardiovascular Disease

The World Health Organization estimates that by 2015 the number of adults who are overweight (body mass index [BMI], 25.0–29.9 kg/m2) or obese (BMI ≥30 kg/m2) will surpass 1.5 billion.1 Excess body weight is an independent risk factor for mortality.2 Among the constellation of weight-related comorbidities that bring the greatest burden for obese patients and their healthcare providers are diabetes mellitus and cardiovascular disease (CVD). Obesity, diabetes mellitus, and CVD cannot be successfully addressed in isolation; therefore, weight loss achieved by any means is a key component of comprehensive cardiovascular care.3,4 Obesity prevention is the ideal scenario. However, in the midst of an obesity pandemic, treatment options are essential. The initial approach must always address lifestyle and dietary choices, which contribute so greatly to the current obesogenic environment. A healthy lifestyle is easily prescribed but challenging to maintain. Stalonas et al5 demonstrated not only that patients who diet usually regain their lost weight within 5 years but also that the average subject was 1.5 lb heavier at follow-up than on entering the program. A recent systematic review of dietary and lifestyle options demonstrated no conclusive evidence for sustainable weight loss.6 However, it is possible for intensive lifestyle coaching to achieve moderate weight loss, as demonstrated by Appel et al.7 Of their 392 obese subjects, those receiving in-person support lost a mean of 5.1 kg ( P <0.001 for comparison with control subjects) and those receiving only telephone/Internet support lost a mean of 4.6 kg ( P <0.001 for comparison with control subjects) at 24 months. The superiority of bariatric surgery over pharmacological and lifestyle interventions in modulating weight, hyperglycemia, and hypertriglyceridemia has been demonstrated by meta-analysis.8 Few studies have directly compared medical and surgical management of obesity, but 2 head-to-head comparisons …

Incidence and management of bleeding complications after gastric bypass surgery in the morbidly obese

BACKGROUND Bleeding after gastric bypass can be a life-threatening event and challenging to manage. With an increase in the number of bariatric procedures performed in recent years, it is important to be cognizant of the frequency, presentation, and management of this complication. The purpose of the present study was to evaluate the incidence and management of bleeding complications after gastric bypass surgery. METHODS A review of prospectively maintained bariatric surgery databases was conducted at 2 tertiary bariatric units. All patients who presented with gastrointestinal and intra-abdominal bleeding after gastric bypass during a 10-year period were identified, and their charts were reviewed. RESULTS A total of 4466 patients who underwent gastric bypass during the 10-year period had reliable morbidity data available and were included in the present study. Of the 4466 patients, 42 (.94%) experienced a bleeding complication postoperatively. Of these patients, 20 (47.6%) had undergone previous abdominal surgery. Bleeding occurred in the early postoperative period (<30 d) in 30 (71%); the etiology of which included bleeding from the staple lines, iatrogenic visceral injury, or mesenteric vessel bleeding. Early postoperative bleeding required operative intervention to achieve hemostasis in 43%. Late postoperative bleeding (n = 12) were usually secondary to marginal ulceration and warranted surgical intervention in 33.3%. Previously undiagnosed bleeding diatheses were identified in 14.3%. CONCLUSION Gastrointestinal bleeding after gastric bypass, although infrequent, is a difficult clinical scenario. Nonoperative management is feasible for hemodynamically stable patients. Surgical intervention is merited for patients with hemodynamic compromise, those who do not respond to transfusion, and those in whom the bleeding source cannot be adequately identified nonoperatively.

Endoscopic stent management of leaks and anastomotic strictures after foregut surgery

BACKGROUND Anastomotic complications after upper gastrointestinal surgery present an arduous therapeutic challenge. Avoiding revisional surgery is desirable and might be possible with the advent of endoscopically placed stents. We reviewed our experience with endoscopic stent management of anastomotic complications after esophagogastric surgery. METHODS A prospectively maintained database at our surgical endoscopy unit was reviewed to identify patients who had undergone endoscopic stent placement after various foregut procedures. Data were obtained on patient demographics, primary surgical and endoscopic procedures, and outcome. RESULTS From January 2007 to August 2010, 18 patients (12 women, mean age 51 ± 15 yr) underwent endoscopic stent placement for anastomotic complications; 14 were bariatric patients. A total of 31 stents (21 covered metal, 5 salivary, and 5 silicone-coated polyester) were used to treat anastomotic leaks (n = 13), strictures (n = 3), and fistulas (n = 2). Symptomatic improvement occurred in all but 2 patients (89%), and early oral intake was initiated in 11 (61%). Stent treatment was successful in definitively managing the anastomotic complication in 13 (72%) of the 18 patients. Five patients required additional surgical or endoscopic intervention. Stent migration occurred in 4 cases and was amenable to endoscopic management. Two patients died, with both deaths unrelated to stent placement. CONCLUSION Endoscopic stent management of anastomotic complications after foregut surgery is effective in resolving symptoms, expediting enteral nutrition, and particularly successful for treating anastomotic leaks. In the absence of stents specifically designed for surgically altered gastrointestinal anatomy, some factors that might reduce the risk of stent migration include appropriate stent selection, anchoring the stent proximally, and regular surveillance after placement.

Banded Roux-en-Y gastric bypass for the treatment of morbid obesity

BACKGROUND Laparoscopic Roux-en-Y gastric bypass (LRYGB) is the most effective treatment for morbid obesity. The additional benefit of placing a nonadjustable band around the pouch remains to be determined. The objective of this study was to compare outcomes between banded and nonbanded LRYGB patients in a single bariatric center. METHODS A matched cohort analysis was performed between patients who had undergone banded and nonbanded (standard) LRYGB. In the banded bypass cohort, an 8 F, 6.5 cm silastic ring was placed around the proximal gastric pouch. Both cohorts were matched for age, body mass index (BMI), and anastomotic technique. Endpoints included percentage excess weight loss (%EWL), postoperative morbidity, and band-related complications. RESULTS Between January 2007 and July 2010, 134 banded LRYGB were performed (55% female, mean age 45 years). They were compared with a matched cohort of 134 concurrent nonbanded LRYGB patients (67% female, mean age 45.4 years). Mean preoperative BMI was 54.6 and 52.8 kg/m(2), respectively (P = .084). At 24 months postoperatively, the average %EWL was 58.6% in banded bypass patients and 51.4% in the nonbanded group (P = .015). The difference in EWL was more pronounced in super-obese patients than in those with BMI<50 (among super-obese, 57.5% versus 47.6%, P = .003; among those with BMI<50, 62.9% versus 57.9%, P = .406]. There was no difference in early (19.4% versus 19.4%) or late complications (10.4% versus 13.4%, P = .451) between banded and nonbanded LRYGB patients. CONCLUSION Banding the pouch during LRYGB can be performed safely and may provide better weight loss, particularly in super-obese patients. Further prospective and long-term comparative studies of this technique are warranted.